4th Quarter - Report

AVENUE SOLUTIONS for GENENTECH USA, INC.

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to Medicare Part B, CMS coverage and reimbursement, 340b drug pricing program; Continued monitoring of Prescription Drug Pricing Reduction Act of 2019 from 116th Congress; Continued monitoring of Elijah E. Cummings Lower Drug Costs Now Act from 116th Congress; Senate Finance Committee Drug Pricing Reform Principles; Monitor possible healthcare policies in upcoming reconciliation package including: making ACA tax credits/subsidies permanent, adding Medicare enhancements/supplemental benefits (hearing, dental, vision), addressing Medicaid coverage gap, expanding home and community based services, prescription drug reform; H.R. 5376, Build Back Better Act; issues surrounding federal government contracts to acquire doses of Xofluza; PL 117-58 - Infrastructure Investment and Jobs Act (BIF) - issues related to rebate rule delay, repurposed Provider Relief Funds, Medicare savings from single source vial size drug policy and extension of mandatory sequester)

LobbyistCovered position, as disclosed
ELIZABETH MACDONALD BARNETT —
TRACY SPICER —

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5376 (117th)

Medicare/Medicaid MMM

Issues related to Medicare Part B, CMS coverage and reimbursement, 340b drug pricing program; Continued monitoring of drug pricing legislation, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now; Prescription Drug Pricing Reduction Act; Senate Finance Committee Drug Pricing Reform Principles; Proposed repeal of the CMS Rule on Most Favored Nation Model; Delay of the Rebate Rule; PL-117-71 Protecting Medicare and American Families from Sequester Cuts Act - specifically: 6 months relief from 2% Medicare sequester, 4% statutory Pay-As-You-Go Act, 1 year relief of physician conversion factor cuts, 1 year delay of clinical lab (PAMA) cuts, delay of radiation oncology demo

LobbyistCovered position, as disclosed
ELIZABETH MACDONALD BARNETT —
TRACY SPICER —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Bills named: H.R. 3 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.